Source:http://linkedlifedata.com/resource/pubmed/id/12802920
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2003-6-13
|
pubmed:abstractText |
The lung is a relatively rare site for mucosa-associated lymphoid tissue (MALT) lymphomas: we report the largest available single-center series of patients with this presentation. From August 1992 to October 2000, 12 patients with untreated primary low-grade MALT lymphoma of the lung were submitted either to chemotherapy alone (n = 8), surgery alone (n = 2) or surgery plus chemotherapy (n = 2). At diagnosis, 6 (50%) were asymptomatic and 6 (50%) had nonspecific pulmonary symptoms. The most common radiologic findings were a pulmonary infiltrate (7 cases) and a mass lesion (5 cases). Histological diagnosis was obtained with transbronchial lung biopsy/bronchoalveolar lavage (BAL) (6 cases), with transthoracic needle biopsy (1 case), or an open thoracotomy (5 cases). All patients had stage IE. All 12 (100%) achieved complete remission; 3 (25%) local recurrences were observed. The global 6-year survival rate was 100% with a relapse-free survival rate of 50%. In conclusion, these data underline the diagnostic utility of BAL and the therapeutic efficacy of a chemotherapeutic strategy based on regimens such as N-CVP in the context of localized MALT lymphoma of the lung.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1042-8194
|
pubmed:author |
pubmed-author:AlinariLapoL,
pubmed-author:BaccaraniMicheleM,
pubmed-author:BonifaziFrancescaF,
pubmed-author:GabrieleAnnalisaA,
pubmed-author:MusuracaGerardoG,
pubmed-author:PileriStefanoS,
pubmed-author:PolettiVenerinoV,
pubmed-author:StefoniVittorioV,
pubmed-author:TaniMonicaM,
pubmed-author:TuraSanteS,
pubmed-author:ZinzaniPier LuigiPL
|
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
821-4
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12802920-Aged,
pubmed-meshheading:12802920-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12802920-Bronchoalveolar Lavage,
pubmed-meshheading:12802920-Female,
pubmed-meshheading:12802920-Humans,
pubmed-meshheading:12802920-Lung Neoplasms,
pubmed-meshheading:12802920-Lymphoma, B-Cell, Marginal Zone,
pubmed-meshheading:12802920-Male,
pubmed-meshheading:12802920-Middle Aged,
pubmed-meshheading:12802920-Neoplasm Invasiveness,
pubmed-meshheading:12802920-Recurrence,
pubmed-meshheading:12802920-Remission Induction,
pubmed-meshheading:12802920-Retrospective Studies,
pubmed-meshheading:12802920-Survival Analysis
|
pubmed:year |
2003
|
pubmed:articleTitle |
Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients.
|
pubmed:affiliation |
Institute of Hematology and Oncology L. e A. Seràgnoli, University of Bologna, Bologna, Italy. plzinzo@med.unibo.it
|
pubmed:publicationType |
Journal Article
|